PT-141 (Bremelanotide) reconstitution & storage

This page summarises the reconstitution and storage practice reported for PT-141 (Bremelanotide) in laboratory research. PT-141 (Bremelanotide) is supplied lyophilised in sealed glass vials and must be reconstituted with an appropriate aqueous vehicle before use. The reconstituted material has a substantially shorter useful life than the dry lyophilised powder, and storage conditions materially affect activity.

The principal practical decisions when reconstituting a research peptide are: choice of vehicle (bacteriostatic water with 0.9% benzyl alcohol, or sterile water for injection); target concentration (driven by the planned dose volume and the precision of the chosen pipetting equipment); single-use versus multi-dose aliquoting strategy; and storage temperature (refrigeration at 2–8 °C versus freezer at −20 °C or −80 °C). Each of these decisions has methodological implications for downstream activity and should be documented in the research protocol.

Vehicle selection

Bacteriostatic water (sterile water containing 0.9% benzyl alcohol as a bacteriostatic preservative) is the most commonly used vehicle in peptide research because it allows multiple withdrawals from a single reconstituted vial over a 28-day refrigerated period without microbial contamination concern. It is not appropriate for neonatal applications (benzyl-alcohol-associated 'gasping syndrome'), for studies where benzyl alcohol interferes with downstream assays, or for some sensitive cell-culture work. Sterile water for injection is the alternative where benzyl alcohol must be avoided, but single- use aliquoting becomes mandatory because there is no preservative against microbial growth.

Concentration and dose-volume planning

The target reconstituted concentration should be chosen so that the planned dose volume falls within a range that the available pipetting equipment can deliver precisely. For research peptides delivered by subcutaneous injection in rodents, target concentrations are typically in the range that allows a single-injection volume of 50–200 µL per animal. Higher concentrations save vehicle but make small dose corrections more error-prone; lower concentrations require larger injection volumes that may exceed the comfortable subcutaneous capacity.

Storage and stability

Lyophilised PT-141 (Bremelanotide) stored at −20 °C in its original sealed vial has a generally long shelf life (manufacturer-dependent, often 1–3 years). Reconstituted material has a much shorter useful life — typically days to weeks at refrigerator temperature, longer when frozen at −80 °C in single-use aliquots. Repeated freeze-thaw cycles are a common cause of unexplained loss of activity in pre-clinical work; the standard mitigation is to aliquot the reconstituted material into single-use volumes immediately after reconstitution and to thaw only the aliquot needed for the next study day.

Cross-references

For broader reconstitution methodology including aseptic technique, concentration math, and troubleshooting, see the reconstitution master guide and the bacteriostatic-water sourcing and storage page. For storage and freeze-thaw stability across the peptide research workflow, see the storage and freeze-thaw stability guide.

For full PT-141 (Bremelanotide) research context, see the main PT-141 (Bremelanotide) research profile.